Corpus ID: 212563520

Short Term Outcomes of Low Dose Liraglutide in Obese Non Diabetic Indian Subjects-A Real World Experience

@inproceedings{Roy2016ShortTO,
  title={Short Term Outcomes of Low Dose Liraglutide in Obese Non Diabetic Indian Subjects-A Real World Experience},
  author={Roy and Anirban and and Kingshuk},
  year={2016}
}
  • Roy, Anirban, and Kingshuk
  • Published 2016
  • Background: The data regarding weight loss effects of liraglutide in overweight or obese Indian non-diabetic subjects is scanty. The present study aims to investigate the effects of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor activator, on various anthropometric and metabolic parameters in Indian obese nondiabetic patients. Methods: A total of 17 obese Indian non-diabetic patients obese (BMI >= 30 with no co-morbidity) or overweight (BMI >=27 with at least one co-morbidity), taking… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    Figures and Tables from this paper.

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 22 REFERENCES

    2016) US Food and Drug Administration. Guidance for Industry Developing Products for Weight Management

    • O Erin St, AM Shannon, M Carol
    • Food and Nutrition Sciences
    • 2016
    VIEW 1 EXCERPT

    US Food and Drug Administration . Guidance for Industry Developing Products for Weight Management

    • O ErinSt, AM Shannon, M Carol
    • Food and Nutrition Sciences
    • 2016